CRE Homepage About The CRE Advisory Board Newsletter Search Links Representation Comments/Ideas
Data Access
Data Quality
Regulation by Litigation
Regulation by Appropriation
Special Projects
CRE Watch List
OMB Papers
Abstracts and Reviews
Regulatory Review
Voluntary Standards Program
CRE Report Card
Public Docket Preparation
Consumer Response Service
Site Search

Enter keyword(s) to search

®: CRE Regulatory Action of the Week

Developing a Long-Term Strategy for the Regulation of the Products of Biotechnology--Public Meeting
The Food and Drug Administration, the Office of Science and Technology Policy, the Environmental Protection Agency, and the United States Department of Agriculture have announced a public meeting to discuss the memorandum entitled, "Modernizing the Regulatory System for Biotechnology Products," issued by the Executive Office of the President in July 2015. The purpose of the meeting is to inform the public about the activities described in the July 2015 memorandum; invite oral comments from interested parties; and provide information about how to submit written comments, data, or other information to the docket. The meeting will be held on October 30, 2015, in the White Oak Great Room, at FDA's White Oak Campus, Building 31 Conference Center, 10903 New Hampshire Ave., Silver Spring, MD 20993-002.

  • Click here to read the Federal Register notice of this meeting.